Ceradyne, Inc. (Ceradyne), entered into an asset purchase agreement (Asset Purchase Agreement) with Stanley Zalkind and Elizabeth Zalkind (the Zalkinds) and Quest Technology, LP (Quest), a limited partnership owned by the Zalkinds. Under the terms of the Asset Purchase Agreement, Ceradyne
The Zalkinds and Quest later sued Ceradyne, asserting a single cause of action for breach of contract. The Zalkinds and Quest alleged Ceradyne breached the Asset Purchase Agreement by not obtaining timely registration with the Securities and Exchange Commission (SEC) of the Ceradyne stock. Ceradyne filed a cross-complaint against the Zalkinds and Quest, asserting a single cause of action for securities fraud in violation of Corporations Code section 25401. Ceradyne alleged the Zalkinds made misrepresentations and omitted material facts to inflate the value of Quest's assets.
Ceradyne moved for summary judgment on the complaint, and the Zalkinds and Quest moved for summary judgment on the cross-complaint. The trial court granted both motions, and all parties have appealed.
We affirm in full. As to Ceradyne's summary judgment motion, we conclude the Zalkinds and Quest's complaint was time-barred because it was not filed within the 24-month limitations period in section 14.4 of the Asset Purchase Agreement. We hold that the Asset Purchase Agreement's definition of indemnification and damages included the Zalkinds and Quest's direct claim for breach of contract against Ceradyne. We also hold the limitations period is reasonable and enforceable.
As to the Zalkinds and Quest's summary judgment motion, we conclude that under Corporations Code section 25501, Ceradyne has no damages and cannot obtain rescission of the Asset Purchase Agreement. We hold the term "the complaint" referred to in section 25501's definition of a seller's damages means the pleading filed by the seller of the security that asserts a violation of Corporations Code section 25401 (here, Ceradyne's cross-complaint).
Ceradyne designs and manufactures advanced technical ceramic products for industrial, automotive, defense, and commercial uses. Quest, a limited partnership, was an original equipment manufacturer of injection-molded ceramic components. As of May 2004, the Zalkinds owned a 99 percent interest in Quest.
In May 2004, the Zalkinds and Quest entered into the Asset Purchase Agreement with Ceradyne, by which the Zalkinds agreed to sell Quest's assets to Ceradyne for $2.44 million, of which $300,000 was paid in cash and the balance paid with unregistered shares of Ceradyne (the stock consideration).
Section 14 of the Asset Purchase Agreement is entitled "Indemnification." Section 14.2 provides that Ceradyne "shall indemnify, hold harmless and defend the Selling Parties and their respective successors and assigns . . . from and against any and all Damages that arise from or are in connection with: [¶] (a) Any breach of or inaccuracy in any of the representations or warranties of any of [Ceradyne] contained in
Section 14.3 of the Asset Purchase Agreement states: "`
Section 14.4(a) of the Asset Purchase Agreement provides that "[n]o claim for indemnification under this
Pursuant to the Asset Purchase Agreement, the Zalkinds received 71,397 shares of Ceradyne common stock based on the average closing price of
On August 19, 2004, Ceradyne filed the form S-3 registration statement with the SEC for the stock consideration. On September 28, 2004, Stanley Zalkind and Ceradyne's chief financial officer agreed to extend the Asset Purchase Agreement's deadline for registering the stock consideration in section 3.1(b)(ii) for one month from the original date of November 30, 2004. Between November 2004 and March 2005, Ceradyne filed three separate amendments to the form S-3 in response to correspondence from the SEC. The Zalkinds did not invoke section 3.1(b)(ii) of the Asset Purchase Agreement and demand $2.14 million in cash from Ceradyne for failure to timely register the stock consideration. On March 15, 2005, the SEC declared the registration of the stock consideration to be effective.
By April 15, 2005, the Zalkinds had sold 106,500 shares of the stock consideration. Their proceeds from the public sales were $2,351,669.61 based on an average selling price of $22.08 per share.
After May 14, 2004, Quest was operated as a division of Ceradyne with Stanley Zalkind and other key employees still in place. For the remainder of 2004, the Quest division had sales of about $1 million and net income of about $41,000. In 2005, the Quest division experienced a net loss of $33,814, in 2006 a loss of $564,576, and in 2007 a loss of $696,598. In 2007, Ceradyne terminated Stanley Zalkind's employment.
In June 2008, the Zalkinds and Quest filed a complaint against Ceradyne, alleging breach of the registration requirements of section 8.10 of the Asset Purchase Agreement. The Zalkinds and Quest filed a first amended complaint, the operative pleading, in October 2008.
The first amended complaint alleged that Ceradyne breached section 8.10 of the Asset Purchase Agreement by failing to file the form S-3 registration statement within 30 days of May 14, 2004, and by failing to use best efforts to cause the stock consideration to be registered by the SEC. The first amended complaint also alleged the delay in registering the stock consideration meant the Zalkinds could not take advantage of a temporary and
After conducting discovery, Ceradyne filed a cross-complaint against the Zalkinds and Quest in May 2009. The cross-complaint asserted a single cause of action for violation of Corporations Code section 25401 and alleged the Zalkinds made a series of false and misleading statements and omissions of material fact about Quest's revenue projections and customer and market opportunities to induce Ceradyne to enter into the Asset Purchase Agreement and purchase Quest's assets. The cross-complaint sought damages and rescission of the Asset Purchase Agreement.
Ceradyne moved for summary judgment on the first amended complaint on the ground, among others, the Zalkinds and Quest's lawsuit constituted a claim for indemnification under section 14 of the Asset Purchase Agreement but was not filed within 24 months of the closing date of May 14, 2004. The Zalkinds and Quest moved for summary judgment on the cross-complaint on the ground, among others, that Ceradyne suffered no damages under Corporations Code section 25501.
The trial court took the motions under submission after hearing argument of counsel and issued a minute order on November 6, 2009, granting both motions. On December 2, the court signed an order submitted by the Zalkinds and Quest, stating: "Plaintiffs' summary judgment motion is granted with respect to the Cross-complaint on the grounds Cross-Complainant has not suffered any damages and rescission is unavailable because the parties cannot be returned to the status quo ante. Summary judgment i[s] not warranted on any other bases proffered by Plaintiffs. [¶] . . . Cross-[complainant]'s summary judgment motion is granted with respect to the Complaint on the grounds the two-year limitations provision in section 14.4 of the Asset Purchase Agreement executed by the parties bars Plaintiffs' claims. Summary judgment i[s] not warranted on any other bases proffered by Cross-complainant[]."
Judgment was entered on December 14, 2009. After entry of judgment, Ceradyne moved to correct a "clerical error" in the order granting summary judgment, or, alternatively, for reconsideration. In the motion, Ceradyne asserted the statement "Summary judgment i[s] not warranted on any other bases proffered by Cross-complainant[]" was inconsistent with the trial court's tentative ruling, argument and findings at oral argument, and the court's minute order. Ceradyne also asserted the order granting summary
"A trial court properly grants summary judgment where no triable issue of material fact exists and the moving party is entitled to judgment as a matter of law. [Citation.] We review the trial court's decision de novo, considering all of the evidence the parties offered in connection with the motion (except that which the court properly excluded) and the uncontradicted inferences the evidence reasonably supports. [Citation.]" (Merrill v. Navegar, Inc. (2001) 26 Cal.4th 465, 476 [110 Cal.Rptr.2d 370, 28 P.3d 116].)
The trial court concluded the Zalkinds and Quest's complaint was time-barred because it was not filed within the 24-month limitations period prescribed by section 14.4 of the Asset Purchase Agreement. It was undisputed the Zalkinds and Quest filed their lawsuit for breach of contract against Ceradyne more than 24 months after the closing date. If the lawsuit for breach of contract filed by the Zalkinds and Quest is a "claim for indemnification" under section 14 of the Asset Purchase Agreement, then their complaint is time-barred.
After examining the language of section 14 of the Asset Purchase Agreement and relevant law on the meaning of indemnification, we agree with Ceradyne the term "claim for indemnification" as used in the Asset Purchase Agreement includes the Zalkinds and Quest's breach of contract action.
Section 14.4 of the Asset Purchase Agreement states, in relevant part, "[n]o claim for indemnification under this
What does "claim for indemnification" under section 14.4 of the Asset Purchase Agreement mean?
The Zalkinds and Quest argue indemnification under section 14.4 of the Asset Purchase Agreement covers "only claims involving liability or potential liability to third parties or obligations imposed on a party by operation of law" and therefore does not apply to their direct claims against Ceradyne for its alleged breach of the Asset Purchase Agreement. Ceradyne argues the 24-month limitations period of section 14 applies to the Zalkinds and Quest's complaint because section 14 was drafted broadly to encompass "both direct, garden variety breach of contract claims between the parties and claims arising from third parties."
Section 14.2 of the Asset Purchase Agreement provides in relevant part: "Subject to the limitations in
If the word "Damages" in section 14.2 of the Asset Purchase Agreement is replaced by the italicized language from section 14.3, and the words "Buyer" and "Selling Parties" are replaced with the parties' names, the result is the following: "[Ceradyne] shall indemnify, hold harmless and defend the [Zalkinds and Quest] . . . from and against any and all damages, losses incurred by [the Zalkinds and Quest] that arise from or are in connection with: [¶] . . . [¶] (b) Any breach or default by [Ceradyne] of its covenants or agreements contained in this Agreement."
The Zalkinds and Quest alleged they incurred damages and loss arising from Ceradyne's breach of its covenants or agreements contained in the Asset Purchase Agreement. The issue comes down to the meaning of "[Ceradyne] shall indemnify" such loss. Does "indemnify" have the narrow meaning, asserted by the Zalkinds and Quest, of reimbursement for losses to third party claims, or does it have the broader meaning, asserted by Ceradyne, of paying for or reimbursing any claimed loss?
Although indemnity generally relates to third party claims, "this general rule does not apply if the parties to a contract use the term `indemnity' to include direct liability as well as third party liability." (Dream Theater, Inc. v. Dream Theater (2004) 124 Cal.App.4th 547, 555 [21 Cal.Rptr.3d 322].) "[E]ach indemnity agreement is `interpreted according to the language and contents of the contract as well as the intention of the parties as indicated by the contract.'" (Wilshire-Doheny, supra, 83 Cal.App.4th at p. 1396.) When indemnity is expressly provided by contract, the extent of the duty to indemnify must be determined from the contract itself. (Rossmoor, supra, 13 Cal.3d at p. 628; see also Heppler v. J.M. Peters Co. (1999) 73 Cal.App.4th 1265, 1277 [87 Cal.Rptr.2d 497] ["parties to an indemnity contract have great freedom of action in allocating risk, subject to certain limitations of public policy"]; Rooz v. Kimmel (1997) 55 Cal.App.4th 573, 583 [64 Cal.Rptr.2d 177] ["We must determine the scope of a contractual duty of indemnification . . . from the contract itself."]; Myers, supra, 13 Cal.App.4th at pp. 968-969 ["The extent of the duty to indemnify is determined from the contract."].)
In Wilshire-Doheny, supra, 83 Cal.App.4th 1380, the court addressed the issue whether particular indemnity provisions were limited to third party claims. In that case, Stanley Shapiro and Jeffrey R. Matsen were corporate officers of Daishin U.S.A. Co., Ltd. (Daishin USA). (Id. at p. 1384.) Pursuant to three different indemnity provisions, Daishin USA agreed to indemnify Shapiro and Matsen with respect to any action or claim brought against them in their capacity as corporate officers. (Id. at pp. 1387, 1394-1395.) Daishin USA sued Shapiro and Matsen, alleging various causes of action arising out of their conduct as corporate officers. (Id. at pp. 1385-1386.) Shapiro and Matsen prevailed at trial, but the trial court denied their motion for attorney fees, which was based on the indemnity provisions. (Id. at pp. 1387-1388.) The Court of Appeal reversed, rejecting the argument the indemnity provisions were limited to third party claims: "There is nothing in the language of any of the three indemnity provisions specifically limiting their application to third party lawsuits. [Daishin USA] point[s] to no extrinsic evidence introduced to demonstrate that the parties intended these provisions to apply to third party lawsuits only. [Citations.] Thus, it has not been shown the indemnity provisions are inapplicable merely because [Shapiro and Matsen] seek indemnification for attorney's fees and costs incurred in an action brought by the indemnitor . . . ." (Id. at p. 1396.)
Section 14.3 of the Asset Purchase Agreement defines the term "damages" by dividing them into two categories. The first category is "demands, claims, actions, suits, investigations and legal or other proceedings brought against any indemnified party or parties, and any judgments or assessments, fines or penalties rendered therein or any settlements thereof." This category correlates to indemnification of third party claims. The second category is "all liabilities, damages, losses, Taxes, assessments, costs and expenses (including, without limitation, reasonable attorneys' and accountants' fees and expenses) incurred by any indemnified party or parties, to the extent not reimbursed or paid for by insurance, whether or not they have arisen from or were incurred in or as a result of any demand, claim, action, suit, assessment or other proceeding or any settlement or judgment." This category would include damages sought in a direct lawsuit between the parties. The clause
Section 14.5 of the Asset Purchase Agreement is entitled "Notice of Claims." The first sentence of section 14.5 requires prompt notification to the indemnifying party of a claim for indemnity. The second and third sentences distinguish third party claims. The second sentence reads: "In the event of any claim for indemnification hereunder resulting from or in connection with any claim or legal proceeding by a third party, the notice to the indemnifying party shall specify, if known, the amount or any estimate of the amount of the liability arising therefrom." The third sentence provides that neither the indemnified party nor any indemnifying party may settle a claim by a third party without the other party's prior written consent. There would be no need to distinguish third party claims in section 14.5 if "indemnify" only referred to third party claims.
Section 14.6 of the Asset Purchase Agreement is entitled "Third Party Claims" and concerns the indemnifying party's defense obligations. Section 14.6 states, "[i]n connection with any claim giving rise to indemnity hereunder that results or may result from or arises or may arise out of any claim or legal proceeding by a person who is not a party to this Agreement . . . ." This section would not be necessary if indemnification by definition meant only third party claims.
Section 14.8 of the Asset Purchase Agreement, entitled "Subrogation," states, "[i]n the event that an indemnifying party pays all or any portion of a third party claim or demand concerning which the indemnified party submits a claim for indemnification . . ., the indemnifying party shall be subrogated." This passage expressly recognizes subrogation rights to third party claims and would be unnecessary if, by definition, indemnification only applied to third party claims.
Section 14.9 of the Asset Purchase Agreement, entitled "Remedies," states: "The indemnification rights and remedies set forth in this
The Zalkinds and Quest argue the references to third party claims in those sections of the Asset Purchase Agreement were meant to distinguish third party claims from claims arising by operation of law, i.e., liabilities that arise without a demand or claim, such as environmental cleanup. This interpretation might be convincing if the term "indemnify" necessarily refers only to third party claims, as the Zalkinds and Quest argue. However, the term "indemnify" in section 14 is subject to the broader definition that encompasses direct claims, and section 14, read as a whole, makes better sense with that interpretation, rather than the narrow interpretation limiting "indemnify" to third party claims.
The Zalkinds and Quest argue Ceradyne's interpretation of section 14 of the Asset Purchase Agreement would require Ceradyne to defend them in this lawsuit. That result would obtain if section 14.2 were read in isolation: Section 14.2 does require the indemnifying party to "indemnify, hold harmless and defend." (Italics added.) But section 14.2 must be read with section 14.6, which sets forth the rights and duties of defense and applies only to third party claims, and the balance of the Asset Purchase Agreement.
The Zalkinds and Quest argue we must strictly construe the language of section 14 of the Asset Purchase Agreement against Ceradyne because agreements to shorten the statute of limitations are disfavored. In Lewis v. Hopper (1956) 140 Cal.App.2d 365, 367 [295 P.2d 93] (Lewis), the court stated: "`[C]ontractual stipulations which limit the right to sue to a period shorter than that granted by statute, are not looked upon with favor because they are in derogation of the statutory limitation. Hence, they should be construed with strictness against the party invoking them.'" (See also Sanders v. American Casualty Co. (1969) 269 Cal.App.2d 306, 309 [74 Cal.Rptr. 634] ["this general rule is correct . . ."].) In Western Filter Corp. v. Argan, Inc. (9th Cir. 2008) 540 F.3d 947, 952, the court cited that rule and the Lewis case with approval; however, no published California opinion has done so in the over 40 years since Sanders v. American Casualty Co. in 1969.
The Zalkinds and Quest do not contend the shorter limitations period of section 14 of the Asset Purchase Agreement is unreasonable.
Ceradyne's cross-complaint alleged the Zalkinds violated Corporations Code section 25401 by making false statements and omissions in connection with the purchase and sale of the stock consideration under the Asset Purchase Agreement. Ceradyne sought damages and rescission of the Asset Purchase Agreement pursuant to Corporations Code section 25501. The trial court granted the Zalkinds and Quest's motion for summary judgment on the ground Ceradyne suffered no damages under section 25501 from the alleged violations of section 25401.
Ceradyne argues (1) the trial court misinterpreted Corporations Code section 25501 in concluding Ceradyne suffered no damages, and (2) Ceradyne may rescind the Asset Purchase Agreement despite the fact none of the parties to it can restore the consideration.
1. The term "the complaint" as used in the formula for calculating a seller's damages under Corporations Code section 25501 means the pleading by which the seller of the security asserts the violation of Corporations Code section 25401.
2. Ceradyne (the seller of the security) asserted a violation of Corporations Code section 25401 in the cross-complaint; therefore, in this case, the term "the complaint" under Corporations Code section 25501 refers to Ceradyne's cross-complaint, not the complaint filed by the Zalkinds and Quest.
3. Because "the complaint" refers to Ceradyne's cross-complaint under Corporations Code section 25501's formula for calculating a seller's damages, Ceradyne suffered negative damages or no damages based on the undisputed facts.
4. Under the express provisions of Corporations Code section 25501, Ceradyne is not entitled to rescission because the undisputed facts are that the Zalkinds and Quest no longer own the security (the stock consideration) and Ceradyne cannot tender the consideration paid for the security.
Corporations Code section 25501 permits recovery of damages by a seller of a security, as follows: "Damages recoverable under this section by a seller
In this case, Ceradyne is the seller of the security—the stock consideration—and the Zalkinds are the buyers of the security. Ceradyne, the seller, asserted its securities fraud claim against the Zalkinds and Quest by cross-complaint. The issue is, does the term "the complaint" in Corporations Code section 25501 include a seller's cross-complaint, or is the term limited to the complaint, whether filed by the buyer or the seller?
Whether the term "the complaint" includes a seller's cross-complaint directly affects the amount, if any, of Ceradyne's damages. A seller's damages under Corporations Code section 25501 are the difference between "(1) the value of the security at the time of the filing of the complaint plus the amount of any income received by the defendant on the security and (2) the price at which the security was sold plus interest at the legal rate from the date of sale."
The Zalkinds and Quest filed the complaint on June 11, 2008. The value of the security on that date is calculated as follows: $38.43 per share x 107,095 shares = $4,115,661. (All numbers are rounded up or down to the nearest dollar.)
Ceradyne filed its cross-complaint on May 8, 2009. The value of the security on that date is calculated as follows: $19.94 per share x 107,095 shares = $2,135,474.
The Zalkinds received $223,800 in net income from selling 106,500 shares of Ceradyne stock between March 31 and April 12, 2005.
The damages formula in Corporations Code section 25501 produces this result if "the complaint" in this case means the complaint filed by the Zalkinds and Quest:
(1) $4,115,661 (value of the stock when the complaint was filed) + $223,800 (income earned on the stock) = $4,339,461
minus
(2) $2,140,000 (sale price of the stock consideration) + $610,692 (interest to date the complaint was filed)
= 1,588,769 in damages. =========
The damages formula in Corporations Code section 25501 produces this result if "the complaint" in this case means Ceradyne's cross-complaint:
(1) $2,135,474 (value of stock when the cross-complaint was filed) + $223,800 (income earned on the stock) = $2,359,274
minus
= Negative $526,853 thus, no damages. ========
The trial court concluded the valuation date for the stock pursuant to Corporations Code section 25501 was the date the seller's (Ceradyne's) cross-complaint was filed and, apparently accepting the later calculations, found Ceradyne suffered no damages.
When the Legislature intends the word "complaint" to include "cross-complaint," it says so. (E.g., Code Civ. Proc., §§ 425.115, subd. (a) ["As used in this section: [¶] (1) `Complaint' includes a cross-complaint."], 425.16, subd. (h) ["For purposes of this section, `complaint' includes `cross-complaint. . . .'"], 426.10 ["As used in this article: [¶] (a) `Complaint' means a complaint or cross-complaint."], 429.30, subd. (a) ["As used in this section: [¶] (1) `Complaint' includes a cross-complaint."], 430.10 [demurrer or answer may be filed by the "party against whom a complaint or cross-complaint has been filed"], 435, subd. (a) ["As used in this section: [¶]
Similarly, the Legislature will expressly say when "plaintiff" includes "cross-complainant" and "defendant" includes "cross-defendant." (E.g., Code Civ. Proc., §§ 386, subd. (c), 389, 425.115, subd. (a), 425.16, subd. (h), 438, subd. (a), 481.180, 581, subd. (a)(4) & (5), 1031, 1032, subd. (a)(2) & (3), 583.110, subds. (d) & (e).)
In Yao v. Superior Court (2002) 104 Cal.App.4th 327, 329 [127 Cal.Rptr.2d 912], the Court of Appeal concluded the word "plaintiff" in Code of Civil Procedure section 1030, subdivision (a) does not include a cross-complainant because it makes no reference to a cross-complainant. "In sum, the Legislature clearly knows how to indicate when it wants a statutory provision to apply to both a plaintiff and a cross-complainant. It also clearly knows how to indicate that a reference to `plaintiff' must be construed as including a cross-complainant. The Legislature chose not to adopt either option in this case." (Yao v. Superior Court, supra, at p. 332.)
A leading treatise on California securities laws, in explaining a seller's damages under Corporations Code section 25501, also treats the seller as the plaintiff initiating the action and the buyer as the defendant: "In the case of a purchase in violation of these provisions, a plaintiff seller is given a cause of action for damages (when the defendant no longer owns the security) for an amount equal to the difference between (1) the value of the security at the time of the filing of the complaint plus the amount of any income received by the defendant on the security and (2) the price at which the security was sold by the plaintiff plus interest at the legal rate from the date of sale. In such a case, the plaintiff would have been entitled to recover the security itself (and therefore its value at the time of the lawsuit) except for the action of the defendant in disposing of it before the plaintiff brings the action. This action by the defendant, over which the plaintiff had no control, should not result in the plaintiff being entitled to recover less. Therefore, this section provides that the plaintiff may recover the value of the security at the time of the filing of the complaint." (1 Marsh & Volk, Practice Under the Cal. Securities Laws (2010) § 14.03[8][b], p. 14-43 (rel. 38-7/2010).)
Interpreting the term "the complaint" in Corporations Code section 25501 to include a seller's cross-complaint for securities fraud is consistent with the purpose for valuing the stock at the time "the complaint" is filed. That purpose is explained as follows: "[I]t was believed that the proper time at which to value the security for the purpose of computing damages when rescission was unavailable was the time the action was commenced. By that action, the plaintiff has indicated his or her election to repudiate the transaction, and future market changes in the price of a security no longer owned by the defendant should not affect the amount of his or her recovery. If it did, then delays in litigation, perhaps beyond the control of either party, would determine to some extent the substantive rights of the parties." (1 Marsh & Volk, Practice Under the Cal. Securities Laws, supra, § 14.03[8][b], p. 14-43.)
The relation-back doctrine does not extend to Corporations Code section 25501 because its nature and purpose are not the same as or similar to those of a statute of limitations. Ceradyne's cross-complaint therefore does not relate back to the date the complaint was filed for purposes of determining damages.
Ceradyne argues the "price" of the stock consideration was less than $2.14 million because the value of Quest's assets had been inflated by the Zalkinds' fraud. As a result, Ceradyne argues, there is a triable issue of material fact as to whether it suffered damages under Corporations Code section 25501.
Undisputed fact No. 1 in the separate statement in support of the Zalkinds and Quest's motion for summary judgment was: "The assets of Quest sold to Ceradyne were valued by Quest and Ceradyne at $2,440,000, as reflected in Exhibit A to the Asset Purchase Agreement . . . . Ceradyne agreed to pay for these assets by giving Stanley Zalkind, Elizabeth Zalkind and Quest . . . $300,000 cash and common stock of Ceradyne valued at $2,140,000." The evidence cited in support of that fact was the declaration of Stanley Zalkind and relevant portions of the Asset Purchase Agreement. Stanley Zalkind's declaration confirmed undisputed fact No. 1. Exhibit A to the Asset Purchase Agreement valued the Quest assets at $2.44 million and confirmed Ceradyne purchased those assets by paying the Zalkinds $300,000 in cash and common stock of Ceradyne valued at $2.14 million. Thus, the Zalkinds established the "price" of the stock consideration was $2,440,000 - $300,000 = $2,140,000.
Ceradyne, in its response to undisputed fact No. 1, stated: "To the extent Ceradyne . . . `valued' Quest Technology LP's . . . assets at $2,440,000,
Ceradyne argues the Moskowitz declaration "creates a material issue of fact as to the `price of the security' and affecting the damages calculation under the statutory formula." We disagree. The Moskowitz declaration speaks entirely in generalities. Drawing the inference from the declaration the value of Quest's assets was inflated, the Moskowitz declaration does not state the amount by which the value of those assets was inflated. Even if the Moskowitz declaration raised a triable issue, the issue is not material because Ceradyne failed to show the value of the Quest assets was inflated to a degree sufficient to create damages under the required statutory formula. To establish damages, Ceradyne had to show Quest's assets were inflated by at least $826,853, thereby reducing their value from $2,440,000 (the value set forth in the Asset Purchase Agreement) to $1,613,147
We conclude Ceradyne failed to produce sufficient evidence in opposition to the Zalkinds and Quest's motion for summary judgment to create a triable issue of material fact as to the price at which the Ceradyne stock was sold.
In granting the Zalkinds and Quest's motion for summary judgment, the trial court concluded Ceradyne could not obtain rescission of the Asset Purchase Agreement because "the parties cannot be returned to the status quo." Ceradyne argues the trial court erred and rescission is permissible because, to the extent the consideration cannot be restored, the court can balance the equities with cash transfers.
In addition, Corporations Code section 25501 provides that "[u]pon rescission, a seller may recover the security, upon tender of the consideration paid for the security plus interest at the legal rate, less the amount of any income received by the defendant on the security." Ceradyne cannot tender the consideration (the Quest assets) received in exchange for the stock consideration.
In November 2007, Ceradyne moved what had been Quest's tangible personal property from Quest's former San Diego office to Ceradyne's offices in Costa Mesa. Much of the office equipment and property have since been sold, used up, or given away. Also in November 2007, Ceradyne declined to renew the lease on the former Quest offices in San Diego, and the landlord has entered into a lease with a different tenant. Other personal property leases held by Quest have expired. Former Quest employees, who became Ceradyne employees, taught Ceradyne personnel over a period of several months how to use Quest's proprietary process to form and prepare orthodontic brackets. Quest's inventories of finished goods and work in process are long gone. Of Quest's former employees, one remains employed by Ceradyne, and Ceradyne has terminated the employment of the others.
In summary, Quest has been fully absorbed into Ceradyne; Quest's tangible assets have been sold or dissipated; its office lease has expired; its employees have been dispersed; and its proprietary information has been learned by Ceradyne. Ceradyne cannot tender the consideration and therefore cannot obtain rescission as a remedy under Corporations Code section 25501.
Because none of the parties can restore the consideration for the Asset Purchase Agreement, the rescission sought by Ceradyne is really no rescission. Ceradyne proposes adjusting the equities by balancing the value of the assets purchased by Ceradyne against the value of the Ceradyne shares sold to the Zalkinds and Quest to produce a net balance that can be reduced to a money judgment. Ceradyne alleges the value of Quest's assets was inflated, so the hoped-for result of this adjusting of equities would be a net monetary recovery in Ceradyne's favor in the amount of the difference between the value of the Quest assets purchased and the value of the Ceradyne shares sold to the Zalkinds and Quest. What Ceradyne is seeking by "adjusting the equities" is therefore nothing less than a form of monetary recovery that would be inconsistent with the damages limitations of Corporations Code section 25501.
The judgment is affirmed. Because each party prevailed in part, no party shall recover costs incurred on appeal.
O'Leary, Acting P. J., and Moore, J., concurred.